Skip to search formSkip to main contentSkip to account menu

(123I)iomazenil

Known as: Iomazenil I-123, IOMAZENIL (123I), hyl 5,6-dihydro-7-iodo-(sup 123 sup)I-5-methyl-6-oxo-4h-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
A novel series of nonpeptide CCK(2) receptor antagonists has been prepared, in which 2,7-dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h… 
Highly Cited
1998
Highly Cited
1998
We report the cloning, expression, and characterization of a new family of cyclic nucleotide phosphodiesterase (PDE) that has… 
1998
1998
Our study examines the role of central and peripheral neurokinin1 (NK1) receptors in diabetes-induced mechanical hypersensitivity… 
1996
1996
Quantitation of metabolic processes with dynamic positron emission tomography (PET) and tracer kinetic modelling relies on the… 
1996
1996
SummaryIomazenil is a specific ligand for central-type benzodiazepine receptors (BZR). In order to determine the clinical… 
1996
1996
A receptor mapping technique using iodine-123 iomazenil and single-photon emission tomography (SPET) was employed to examine… 
1994
1994
BACKGROUND Modulators of the 'classical' multidrug resistance (mdr) phenotype have low efficacy in patients with solid tumors. We… 
1993
1993
Factors contributing to the quantification of the central benzodiazepine receptor binding potential in vivo using 123I-iomazenil…